Filing Details
- Accession Number:
- 0001144204-13-053097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-30 16:21:49
- Reporting Period:
- 2013-09-24
- Filing Date:
- 2013-09-30
- Accepted Time:
- 2013-09-30 16:21:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368953 | Antony Pfaffle | C/O Cormedix Inc. 745 Route 202-206, Suite 303 Bridgewater NJ US 08807 | Interim Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Disposition | 2013-09-24 | 125 | $0.92 | 16,725 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | Acquisiton | 2013-03-20 | 210,000 | $0.00 | 210,000 | $0.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 210,000 | 2023-03-22 | No | 4 | A | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $0.68 | 2022-12-05 | 250,000 | 250,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $0.29 | 2022-01-06 | 30,000 | 30,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $2.10 | 2021-01-14 | 30,000 | 30,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $3.13 | 2020-03-30 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-12-05 | 250,000 | 250,000 | Direct |
| 2022-01-06 | 30,000 | 30,000 | Direct |
| 2021-01-14 | 30,000 | 30,000 | Direct |
| 2020-03-30 | 20,000 | 20,000 | Direct |
Footnotes
- The sale was effected by Dr. Pfaffle's broker without his knowledge as part of an account fee payment.
- These options vest based on performance milestones running through December 31, 2014.
- These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.
- The options vest in full on the first anniversary of the date of grant.
- These options vest on January 14, 2012.
- These options vest as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
Billionaire Hedge Funds
